Michele Tana, MD

Education
2020 - Diversity, Equity, and Inclusion Champion Training, University of California
M.H.S., 2016 - Clinical Research, Duke University
Hepatology, 2013 - NIDDK, National Institutes of Health
Gastroenterology, 2011 - Department of Medicine, California Pacific Medical Center
Internal Medicine, 2008 - School of Medicine, Stanford University
M.D., 2005 - Medical Schoool, Harvard University
A.B., 2000 - Classics, Harvard College
Websites
Publications

  1. Satre DD, Dasarathy D, Batki SL, Ostacher MJ, Snyder HR, Hua W, Parekh P, Shui AM, Cheung R, Monto A, Wong RJ, Chen JY, Liao M, Tana M, Chen PH, Haight CG, Fakadej T, Khalili M. Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease. Alimentary pharmacology & therapeutics 2024. PMID: 39523996


  2. Klepper A, Kung A, Vazquez SE, Mitchell A, Mann S, Zorn K, Avila-Vargas I, Kari S, Tekeste M, Castro J, Lee B, Duarte M, Khalili M, Yang M, Wolters P, Price J, Perito E, Feng S, Maher JJ, Lai J, Weiler-Normann C, Lohse AW, DeRisi J, Tana M. Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights. medRxiv : the preprint server for health sciences 2023. PMID: 37398174


  3. Hundt M, Chen A, Donovan J, Kim N, Yilma M, Tana M, Mehta N, Zhou K. Barriers to liver transplant referral in safety net settings: A national provider survey. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024. PMID: 38687168


  4. Feuille C, Kari S, Patel R, Oberoi R, Liu J, Ohliger M, Khalili M, Tana M. Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease. Scientific Reports 2024. PMID: 38242967


  5. Patel S, Kim RG, Shui AM, Magee C, Lu M, Chen J, Tana M, Huang CY, Khalili M. Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use. Gastro Hep Advances 2023. PMID: 39100862


  6. Bositis CM, Tana MM. Timely Treatment Translates: A Vision for Eradicating HCV. NAM perspectives 2023. PMID: 37916069


  7. Yilma M, Kim NJ, Shui AM, Tana M, Landis C, Chen A, Bangaru S, Mehta N, Zhou K. Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals. JAMA network open 2023. PMID: 37289453


  8. Hercun J, Noureddin M, Noureddin N, Eccleston J, Woolridge D, Liang TJ, Tana M, Kleiner DE, Rodriguez GV, Koh C, Hoofnagle JH, Heller T. Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis. The American journal of gastroenterology 2022. PMID: 36066458


  9. Tana MM, Klepper A, Lyden A, Pisco AO, Phelps M, McGee B, Green K, Feng S, DeRisi J, Crawford ED, Lammert CS. Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management. . 2022. PMID: 35312680


  10. Wang CW, Grab J, Tana MM, Irani RA, Sarkar M. Outcomes of Pregnancy in Autoimmune Hepatitis: A Population-Based Study. Hepatology (Baltimore, Md.) 2021. PMID: 34455632


  11. Sangaramoorthy M, Yang J, Guan A, DeRouen MC, Tana MM, Somsouk M, Thompson CA, Gibbons J, Ho C, Chu JN, Cheng I, Gomez SL, Shariff-Marco S. Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update. . 2021. PMID: 34853019


  12. Deng LX, Tana MM, Lai JC. Thinking Ahead: Advance Care Planning for Patients With Cirrhosis. . 2021. PMID: 35106142


  13. Lee BT, Tana MM, Kahn JA, Dara L. We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases. Hepatology (Baltimore, Md.) 2021. PMID: 34056734


  14. Gara N, Tana MM, Kattapuram M, Auh S, Sullivan L, Fryzek N, Walter M, Umarova R, Zhao X, Cloherty G, Doo E, Heller T, Liang TJ, Ghany MG. Prospective Study of Withdrawal of Antiviral therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response. Hepatology communications 2021. PMID: 34558806


  15. Tana MM, McCoy D, Lee B, Patel R, Lin J, Ohliger MA. Texture features from computed tomography correlate with markers of severity in acute alcohol-associated hepatitis. Scientific Reports 2020. PMID: 33087739


  16. Huynh MP, Bradshaw PT, Tana MM, Rachocki C, Somsouk M. Obesity and metabolic outcomes in a safety-net health system. Biodemography and social biology 2020. PMID: 32727275


  17. Sangaramoorthy M, Yang J, DeRouen MC, Ho C, Somsouk M, Tana MM, Thompson CA, Gibbons J, Gomez SL, Shariff-Marco S. Disparities in Hepatocellular Carcinoma Incidence in California: An Update. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019. PMID: 31719066


  19. Kapuria D, Ben-Yakov G, Ortolano R, Cho MH, Kalchiem-Dekel O, Takyar V, Lingala S, Gara N, Tana M, Kim YJ, Kleiner DE, Young NS, Townsley DM, Koh C, Heller T. The Spectrum of Hepatic Involvement in Patients with Telomere Disease. Hepatology (Baltimore, Md.) 2019. PMID: 30791107


  20. Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM. Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved. Autoimmunity 2018. PMID: 29890851


  21. Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana MM. Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans. Volume 113 of Issue 2. The American journal of gastroenterology 2018. PMID: 29380822


  22. Baghdanian AH, Baghdanian AA, Puppala S, Tana M, Ohliger MA. Imaging Manifestations of Peptic Ulcer Disease on Computed Tomography. Seminars in ultrasound, CT, and MR 2017. PMID: 29571554


  23. Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y. Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms Fatigue: Biomedicine, Health & Behavior. 2017. PMID:


  24. Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Rehman RB, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y. Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms. Fatigue : biomedicine, health & behavior 2017. PMID: 30546968


  25. Tana MM, Muir AJ. Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue? Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017. PMID: 28694131


  26. van Wijk XMR, Magee CA, Wu AHB, Tana MM, Lynch KL. A comparison of methods for evaluation of a case of suspected macro-aspartate aminotransferase. Clinica chimica acta; international journal of clinical chemistry 2016. PMID: 27732874


  28. Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies. Journal of clinical gastroenterology 2016. PMID: 26583267


  29. Tana MM, Shums Z, Milo J, Norman GL, Leung PS, Gershwin ME, Noureddin M, Kleiner DE, Zhao X, Heller T, Hoofnagle JH. The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis. American journal of clinical pathology 2015. PMID: 26386081


  30. Tana MM, Zhao X, Bradshaw A, Moon MS, Page S, Turner T, Rivera E, Kleiner DE, Heller T. Factors associated with the platelet count in patients with chronic hepatitis C. Thrombosis research 2015. PMID: 25728497


  31. Tana MM, Heller T. Autoantibodies in hepatitis C: red flag or bystander effect? Journal of pediatric gastroenterology and nutrition 2013. PMID: 23443062


  32. Tana MM, Ghany MG. Hepatitis B virus treatment: Management of antiviral drug resistance. Clinical liver disease 2013. PMID: 30992816


  33. Tana MM, Hoofnagle JH. Scar undone: long-term therapy of hepatitis B. Lancet (London, England) 2012. PMID: 23234726